Literature DB >> 9133552

Regulation of glomerular epithelial cell production of fibronectin and transforming growth factor-beta by high glucose, not by angiotensin II.

N F van Det1, N A Verhagen, J T Tamsma, J H Berden, J A Bruijn, M R Daha, F J van der Woude.   

Abstract

Accumulation of matrix proteins is a prominent feature of diabetic nephropathy. Glomerular visceral epithelial cells (GVECs) are important contributors to extracellular matrix (ECM) production in the glomerulus. Factors involved with increased accumulation of ECM proteins are high glucose, angiotensin II (ANG II), and transforming growth factor (TGF)-beta. Therefore, we investigated the effects of high glucose and ANG II on fibronectin and TGF-beta production by human GVECs in vitro. We found that ANG II had no effect on the production of fibronectin and TGF-beta by GVECs. Using reverse transcriptase-polymerase chain reaction analysis, no ANG II receptor could be detected on these cells. However, high glucose induced a twofold increase in fibronectin (P < 0.01) and a three- to sixfold increase in TGF-beta (P < 0.001) production. Similar results were obtained by analyzing the mRNA levels of fibronectin (increased 2.7-fold) and TGF-beta (increased 3.5-fold). Addition of increasing concentrations of rTGF-beta to control cells resulted in increased fibronectin production. Neutralizing antibodies against TGF-beta significantly reversed the increase in fibronectin protein and mRNA caused by high glucose back to control levels. We conclude that high glucose concentrations stimulate the synthesis of fibronectin and that this effect is mediated by induction of TGF-beta. These results suggest that in diabetic nephropathy, high glucose levels play a role in changing the matrix composition of the glomerular basement membrane through induction of TGF-beta. Our results indicate that a contribution to this process by an effect of ANG II on GVECs seems unlikely.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9133552     DOI: 10.2337/diab.46.5.834

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  6 in total

1.  Transforming growth factor-beta1 is up-regulated by podocytes in response to excess intraglomerular passage of proteins: a central pathway in progressive glomerulosclerosis.

Authors:  Mauro Abbate; Carla Zoja; Marina Morigi; Daniela Rottoli; Stefania Angioletti; Susanna Tomasoni; Cristina Zanchi; Lorena Longaretti; Roberta Donadelli; Giuseppe Remuzzi
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 2.  TGF-beta: a crucial component of the pathogenesis of diabetic nephropathy.

Authors:  S Goldfarb; F N Ziyadeh
Journal:  Trans Am Clin Climatol Assoc       Date:  2001

3.  Effects of advanced glycosylation endproducts on perlecan core protein of glomerular epithelium.

Authors:  Tae-Sun Ha; Chang-Ju Song; Joon-Ho Lee
Journal:  Pediatr Nephrol       Date:  2004-09-22       Impact factor: 3.714

4.  Regulation of transforming growth factor beta in diabetic nephropathy: implications for treatment.

Authors:  Yanqing Zhu; Hitomi Kataoka Usui; Kumar Sharma
Journal:  Semin Nephrol       Date:  2007-03       Impact factor: 5.299

5.  Expression and regulation of latent TGF-beta binding protein-1 transcripts and their splice variants in human glomerular endothelial cells.

Authors:  Joon Hyeok Kwak; Ji Su Woo; Kunyoo Shin; Hee Joon Kim; Hoe Su Jeong; Dong Cheol Han; Sung Il Kim; Choon Sik Park
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153

6.  The Expression of miR-192 and Its Significance in Diabetic Nephropathy Patients with Different Urine Albumin Creatinine Ratio.

Authors:  Xiaoyu Ma; Canlu Lu; Chuan Lv; Can Wu; Qiuyue Wang
Journal:  J Diabetes Res       Date:  2016-01-05       Impact factor: 4.011

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.